ChristianaCare Study Points to Potential New Drug Combination Strategy for Colorectal Cancer
ChristianaCare Study Points to Potential New Drug Combination Strategy for Colorectal Cancer ChristianaCare News
Онкология
Колоректальный рак
210 материалов по теме, собраны автоматически из проверенных источников
Онкология
Registration Opens for Paris Colon Cancer Congress 2026 – GI Cancers Alliance
Registration Opens for Paris Colon Cancer Congress 2026 – GI Cancers Alliance Oncodaily
Онкология
Phanes Therapeutics announces first patient with colorectal cancer (CRC) dosed in clinical study of spevatamig
Phanes Therapeutics announces first patient with colorectal cancer (CRC) dosed in clinical study of spevatamig PR Newswire
Онкология
ctDNA-Guided Adjuvant Therapy Misses Primary End Point in Colon Cancer Trial
ctDNA-Guided Adjuvant Therapy Misses Primary End Point in Colon Cancer Trial Targeted Oncology
:og(360tv.ru,%27%D0%92%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D1%83%20%D0%BE%D1%82%C2%A0%D0%BA%D0%BE%D0%BB%D0%BE%D1%80%D0%B5%D0%BA%D1%82%D0%B0%D0%BB%D1%8C%D0%BD%D0%BE%D0%B3%D0%BE%20%D1%80%D0%B0%D0%BA%D0%B0%20%C2%AB%D0%9E%D0%BD%D0%BA%D0%BE%D1%80%D0%BD%D0%B0%C2%BB%20%D0%B2%D0%BA%D0%BB%D1%8E%D1%87%D0%B0%D1%82%20%D0%B2%C2%A0%D0%9E%D0%9C%D0%A1%20%D1%81%C2%A02027%20%D0%B3%D0%BE%D0%B4%D0%B0%27):format(jpg)/YXJ0aWNsZXMvaW1hZ2UvMjAyNi8xMC9yaWEtODE4OTEyNG1yMTAwMF9OQm9UcFVNLmpwZw.jpg)
Онкология
Вакцину от колоректального рака «Онкорна» включат в ОМС с 2027 года
Вакцину от колоректального рака «Онкорна» включат в ОМС с 2027 года 360.ru
Онкология
Liver transplant for colorectal liver metastases ‘promising’
NASHVILLE, Tenn. — Liver transplantation yielded favorable short- and intermediate-term outcomes for patients with unresectable colorectal liver metastases confined to the liver, according to a study presented at ACG Annual Meeting. Additionally, incidence of graft-related mortality after transplant was low, with most…
Онкология
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer BioSpace
Онкология
No approved treatment exists for colorectal cancer patients with cancer signals but clear scans. A trial will test one.
No approved treatment exists for colorectal cancer patients with cancer signals but clear scans. A trial will test one. Stock Titan
Онкология
FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer
FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer Mega Doctor News
Онкология
Vijay Shah: FDA Approves Atezolizumab for Stage III dMMR Colon Cancer
Vijay Shah: FDA Approves Atezolizumab for Stage III dMMR Colon Cancer Oncodaily
:focal(0.5:0.42):og(360tv.ru,%27%D0%90%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7%20%D0%BD%D0%B0%20%D1%81%D0%BA%D1%80%D1%8B%D1%82%D1%83%D1%8E%20%D0%BA%D1%80%D0%BE%D0%B2%D1%8C%20%D0%BF%D0%BE%D0%BC%D0%BE%D0%B3%20%D0%B2%D0%BE%D0%B2%D1%80%D0%B5%D0%BC%D1%8F%20%D0%B2%D1%8B%D1%8F%D0%B2%D0%B8%D1%82%D1%8C%20%D1%80%D0%B0%D0%BA%20%D0%BA%D0%B8%D1%88%D0%B5%D1%87%D0%BD%D0%B8%D0%BA%D0%B0%20%D1%83%20%D0%B6%D0%B8%D1%82%D0%B5%D0%BB%D1%8F%20%D0%9F%D0%BE%D0%B4%D0%BC%D0%BE%D1%81%D0%BA%D0%BE%D0%B2%D1%8C%D1%8F%27):format(jpg)/YXJ0aWNsZXMvaW1hZ2UvMjAyNi8xMC9pbWctMjA3M19xU2dlaVd0LmpwZw.jpg)
Онкология
Анализ на скрытую кровь помог вовремя выявить рак кишечника у жителя Подмосковья
Анализ на скрытую кровь помог вовремя выявить рак кишечника у жителя Подмосковья 360.ru
Онкология
Colorectal cancer mortality falling, but ‘hotspots’ remain
Colorectal cancer mortality has declined sharply among adults aged 45 years and older across the U.S. since 2000, but some counties continue to have exceedingly high rates among certain racial and ethnic populations. These “hotspots” are most prevalent among Black men in the Southeast and American Indian or Alaska…
Онкология
Eddingpharm's GB268 Phase 2 Colorectal Cancer Trial Cleared by China's NMPA
Eddingpharm's GB268 Phase 2 Colorectal Cancer Trial Cleared by China's NMPA BigGo Finance
Онкология
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer BioPharma APAC
Онкология
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer BioPharma APAC